Back to Search
LISA TANNOCK, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1720092661Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
38487(KY)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
38487(KY)
Research & Publications (20)
Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis.
PMID 18584330·Rev Endocr Metab Disord·2008
6-review
Advances in the management of hyperlipidemia-induced atherosclerosis.
PMID 18327996·Expert Rev Cardiovasc Ther·2008
6-review
Management of dyslipidemia in patients after solid organ transplantation.
PMID 18467808·Postgrad Med·2008
6-review
Glucosamine supplementation accelerates early but not late atherosclerosis in LDL receptor-deficient mice.
PMID 17056813·J Nutr·2006
7-preclinical
A murine model of obesity with accelerated atherosclerosis.
PMID 19498343·Obesity (Silver Spring)·2010
7-preclinical
HDL remodeling during the acute phase response.
PMID 19008529·Arterioscler Thromb Vasc Biol·2009
8-other
Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice.
PMID 19592463·Arterioscler Thromb Vasc Biol·2009
4-observational
Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner.
PMID 18974302·Am J Pathol·2008
7-preclinical
Management of new-onset diabetes mellitus after transplantation.
PMID 18654070·Postgrad Med·2008
6-review
Glucosamine inhibits the synthesis of glycosaminoglycan chains on vascular smooth muscle cell proteoglycans by depletion of ATP.
PMID 18484279·Arch Physiol Biochem·2008
7-preclinical
SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance.
PMID 18064300·J Clin Invest·2008
7-preclinical
Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development.
PMID 18033753·J Lipid Res·2008
7-preclinical
Regulation of vascular proteoglycan synthesis by metabolic factors associated with diabetes.
PMID 17441408·J Investig Med·2007
7-preclinical
Differential effects of rosiglitazone and insulin glargine on inflammatory markers, glycemic control, and lipids in type 2 diabetes.
PMID 17239474·Diabetes Res Clin Pract·2007
2-rct
Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects.
PMID 15939816·Circulation·2005
4-observational
Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.
PMID 15343384·J Clin Invest·2004
7-preclinical
Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans.
PMID 15071727·Diabetologia·2004
7-preclinical
Lipoprotein-matrix interactions in macrovascular disease in diabetes.
PMID 14977582·Front Biosci·2004
6-review
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL.
PMID 12923222·J Lipid Res·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 740 S LIMESTONE
LEXINGTON, KY 40536 - Phone
- (859) 323-5981
Quick Facts
- NPI
- 1720092661
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile